Home Regeneron Pharms Receives Neutral Rating from Zacks
 

Keywords :   


Regeneron Pharms Receives Neutral Rating from Zacks

2013-02-19 04:07:39| Biotech - Topix.net

's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday.

Tags: rating receives neutral zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11New2DS LL ×AC
25.11Playstation vita Wi-Fi
25.11 UGC
25.11
25.11Soomloom
25.11BMW Z4 M coupe 2009 PMA
25.11 DVD-BOX
25.11(mizuki) ()
More »